Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 16, 2017 07:00 ET | Source: MediWound Ltd.

MediWound Reports Third Quarter 2017 Financial Results

NexoBrid® sales grow 74% year-to-date Raised gross proceeds of $25.2 million through public equity offering Awarded additional $32 million from BARDA to support NexoBrid R&D programs ...
November 13, 2017 21:33 ET | Source: MediWound Ltd.

Tel Aviv District Court Ordered MediWound to Purchase Approximately $1.5 Million of PolyHeal Shares; MediWound Weighing an Appeal

YAVNE, Israel, Nov. 13, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
November 10, 2017 16:01 ET | Source: MediWound Ltd.

MediWound to Host Third Quarter 2017 Financial Results Conference Call on November 16, 2017 at 8:30 a.m. Eastern Time

YAVNE, Israel, Nov. 10, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
October 27, 2017 07:00 ET | Source: MediWound Ltd.

MediWound Announces Exercise of Underwriters’ Option to Purchase Additional Shares

YAVNE, Israel, Oct. 27, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
October 25, 2017 07:00 ET | Source: MediWound Ltd.

MediWound Appoints Mr. Stephen T. Wills as Chairman to its Board of Directors

YAVNE, Israel, Oct. 25, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe burn...
October 16, 2017 08:00 ET | Source: MediWound Ltd.

MediWound Further Expands NexoBrid’s® Global Outreach through New Distribution Agreement in Taiwan with Holy Stone Healthcare

YAVNE, Israel, Oct. 16, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company specializing in the development of innovative therapies to address unmet...
September 19, 2017 06:30 ET | Source: MediWound Ltd.

MediWound Ltd. Announces Pricing of $22 Million Public Offering of Ordinary Shares

YAVNE, Israel, Sept. 19, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD) today announced the pricing of an underwritten public offering of 4,400,000 of its ordinary shares at a price to the...
September 18, 2017 16:07 ET | Source: MediWound Ltd.

MediWound Ltd. Announces Public Offering of Ordinary Shares

YAVNE, Israel, Sept. 18, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a fully integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe...
September 11, 2017 07:30 ET | Source: MediWound Ltd.

MediWound’s NexoBrid® Wins Best Poster Presentation Award at the 17th European Burns Association Congress

Award-winning Poster Underscores European Consensus on Benefits of NexoBrid YAVNE, Israel, Sept. 11, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical...
September 06, 2017 07:30 ET | Source: MediWound Ltd.

MediWound’s NexoBrid® Highlighted in 43 Presentations at the 17th European Burns Association Congress

YAVNE, Israel, Sept. 06, 2017 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company specializing in innovative therapies to address unmet needs in severe...